Funder
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Green, S. K., Karlsson, M. C., Ravetch, J. V. & Kerbel, R. S. Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer. Cancer Res 62, 6891–6900 (2002).
2. Lavin, S. R., McWhorter, T. J. & Karasov, W. H. Mechanistic bases for differences in passive absorption. J Exp Biol 210, 2754–2764,
https://doi.org/10.1242/jeb.006114
(2007).
3. Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46, 3–26 (2001).
4. Fessler, S. P., Wotkowicz, M. T., Mahanta, S. K. & Bamdad, C. MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells. Breast Cancer Res Treat 118, 113–124,
https://doi.org/10.1007/s10549-009-0412-3
(2009).
5. Oliveras-Ferraros, C. et al. Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux) efficacy in KRAS wild-type tumor cells. J Cell Biochem 112, 10–29,
https://doi.org/10.1002/jcb.22952
(2011).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献